Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$507,936
+$191,951 QoQ
Shares Held
14,800
+11.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#141
of 274 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWINBEECH CAPITAL LP holds $19,348,066 across 17 Biotechnology names. BEAM ranks #12 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
18,135 | $4,438,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,325 | $4,312,254 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
42,192 | $2,452,620 | |
| 4 | INSM |
INSMED Inc
|
13,646 | $1,454,936 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
31,387 | $1,214,676 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
9,900 | $737,352 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
16,200 | $695,142 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
28,337 | $682,354 |
All Filings in BEAM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $507,936 | 14,800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $315,985 | 13,260 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $813,690 | 47,836 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,665,970 | 238,913 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,166,067 | 127,664 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,426,096 | 58,208 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $1,144,538 | 34,641 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $410,172 | 12,846 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,912,592 | 127,779 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,392,290 | 50,216 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||